Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KVUE

Kenvue Inc

Nov 11 • 04:00PM ET

16.72

-0.05 -0.30 %

Consumer Defensive • Household & Personal Products • USA • NYSE

Peers: PG CL CHD JNJ EL KMB UL REYN ULTA

| Held by: VTI VOO VO IVV SPY SDY XLP VTV MOAT VOE

Scroll to Statements

Index	S&P 500	P/E	22.47	EPS (ttm)	0.74	Insider Own	0.05%	Shs Outstand	1.92B	Perf Week	4.70%
Market Cap	32.03B	Forward P/E	15.11	EPS next Y	1.11	Insider Trans	0.00%	Shs Float	1.91B	Perf Month	3.08%
Enterprise Value	40.00B	PEG	18.12	EPS next Q	0.23	Inst Own	99.94%	Short Float	1.37%	Perf Quarter	-22.98%
Income	1.43B	P/S	2.13	EPS this Y	-9.47%	Inst Trans	1.13%	Short Ratio	0.73	Perf Half Y	-29.33%
Sales	15.01B	P/B	3.01	EPS next Y	7.23%	ROA	5.29%	Short Interest	26.15M	Perf YTD	-21.69%
Book/sh	5.55	P/C	28.12	EPS next 5Y	1.24%	ROE	13.47%	52W High	25.17 -33.57%	Perf Year	-27.21%
Cash/sh	0.59	P/FCF	19.62	EPS past 3/5Y	-20.60% -6.66%	ROIC	8.05%	52W Low	14.02 19.26%	Perf 3Y	-
Dividend Est.	0.83 (4.94%)	EV/EBITDA	12.13	Sales past 3/5Y	0.91% 1.54%	Gross Margin	58.21%	Volatility	2.88% 4.22%	Perf 5Y	-
Dividend TTM	0.83 (4.94%)	EV/Sales	2.67	EPS Y/Y TTM	34.54%	Oper. Margin	18.20%	ATR (14)	0.67	Perf 10Y	-
Dividend Ex-Date	Nov 12, 2025	Quick Ratio	0.69	Sales Y/Y TTM	-2.94%	Profit Margin	9.55%	RSI (14)	57.55	Recom	2.59
Dividend Gr. 3/5Y	- -	Current Ratio	0.98	EPS Q/Q	3.97%	SMA20	8.39%	Beta	0.57	Target Price	19.09
Payout	150.50%	Debt/Eq	0.86	Sales Q/Q	-3.51%	SMA50	0.68%	Rel Volume	0.80	Prev Close	16.77
Employees	22000	LT Debt/Eq	0.67	Earnings	Nov 03 BMO	SMA200	-19.97%	Avg Volume	36.03M	Price	16.72
IPO	May 04, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.61% -1.46%	Trades		Volume	28,741,500	Change	-0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-25	Downgrade	Canaccord Genuity	Buy → Hold	$15
Sep-26-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy	$22
Apr-10-25	Initiated	Redburn Atlantic	Neutral	$23.50
Mar-24-25	Initiated	Evercore ISI	In-line	$25
Jan-06-25	Upgrade	Piper Sandler	Neutral → Overweight	$21 → $26
Dec-12-24	Downgrade	Deutsche Bank	Buy → Hold	$25 → $24
Sep-24-24	Initiated	Jefferies	Buy	$27
Sep-24-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$24
May-28-24	Resumed	Citigroup	Neutral	$21
Apr-11-24	Initiated	Bernstein	Underperform	$18
Apr-03-24	Initiated	William Blair	Mkt Perform
Mar-01-24	Resumed	Goldman	Neutral	$20
Nov-17-23	Initiated	Piper Sandler	Neutral	$20
Sep-11-23	Upgrade	Deutsche Bank	Hold → Buy	$27
Sep-07-23	Initiated	Canaccord Genuity	Buy	$28
Sep-06-23	Initiated	Argus	Hold
Aug-24-23	Upgrade	Goldman	Neutral → Buy	$29
Jul-25-23	Initiated	Edward Jones	Buy
Jun-01-23	Initiated	HSBC Securities	Hold	$27
May-30-23	Initiated	UBS	Neutral	$28

Show Previous Ratings

Nov-09-25 12:42PM	Kenvue (KVUE) Jumps 17% on Strong Earnings, Kimberly-Clark $48.7-Billion Merger (Insider Monkey)
06:54AM	Kenvue (KVUE) Announces Financial Results for Q3 2025 (Insider Monkey)
Nov-07-25 07:38PM	Nothing to Celebrate: The Median Age of First-Time Home Buyers Hits 40. (Barrons.com)
05:22PM	The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week (The Wall Street Journal)
02:00AM	Why Staples Aren't Safe Anymore-and 11 Stocks That May Be Worth a Look (Barrons.com)
12:00PM	Loading…
Nov-06-25 12:00PM	Halper Sadeh LLC Encourages JAMF, SNDA, KVUE, SM Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
04:44AM	Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks. (Motley Fool)
Nov-05-25 11:43AM	Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction (MarketBeat)
11:36AM	No Tylenol-Kleenex Deal Might Be Best for Dividend Investors (Barrons.com)
05:58AM	Kimberly-Clark (KVUE) Buying Kenvue Isn't A Mistake, Asserts Jim Cramer (Insider Monkey)
Nov-04-25 03:46PM	What Could Stop Kimberly-Clark's Deal for Kenvue (Barrons.com)
07:25AM	Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn (Pharmaceutical Technology)
07:00AM	A solid earnings season reveals tech strength and consumer weakness (Yahoo Finance)
06:51AM	Kimberly-Clark, Kenvues $48.7B deal among recent multibillion-dollar M&A (Manufacturing Dive)
06:30AM	Unease About Warren Buffetts Retirement Overshadows Berkshire Earnings Beat (The Daily Upside)
06:18AM	Loading…
06:18AM	Kenvue (KVUE) Soars 12% on $48.7-Billion Kimberly-Clark Merger (Insider Monkey)
06:14AM	Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal (GuruFocus.com)
03:23AM	These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? (Motley Fool)
12:04AM	Asian shares trade mixed after AI darlings prop up Wall Street (Associated Press Finance)
12:00AM	All megadeals lead to Washington (Financial Times)
12:00AM	AP Top Extended Financial Headlines at 12:05 a.m. EST (Associated Press Finance)
Nov-03-25 11:33PM	Tylenol maker Kenvue secures deal from consumer goods giant (TheStreet) +12.32%
10:00PM	The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker (The Wall Street Journal)
09:06PM	Kimberly-Clark CEO Mike Hsu goes one-on-one with Jim Cramer (CNBC TV)
08:09PM	Tylenols parent company will combine with the maker of Huggies in a $48.7 billion mega-deal (CNN Business)
07:24PM	Analyst Report: Kenvue Inc. (Morningstar Research)
06:17PM	Does the Market Have Bad Breadth? (Zacks)
05:18PM	Podcast: Nasdaq, S&P 500 Kick Off November With Gains (The Wall Street Journal)
05:13PM	Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue (The Wall Street Journal)
04:54PM	Kimberly-Clark Stock Takes Biggest One-Day Hit Since Black Monday (The Wall Street Journal)
04:54PM	Loading…
04:54PM	Stocks Close Higher on M&A and AI Optimism (Barchart)
04:51PM	Stocks to Watch Monday Recap: Kenvue, IREN, Berkshire, Amazon (The Wall Street Journal)
04:29PM	These Stocks Moved the Most Today: Kenvue, Kimberly-Clark, Amazon, uniQure, Palantir, Idexx, Cipher Mining, and More (Barrons.com)
04:21PM	S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue (Investopedia)
04:20PM	How major US stock indexes fared Monday, 11/3/2025 (Associated Press)
04:02PM	Stock market today: Dow slips, Nasdaq pops as AI optimism sends Amazon, Nvidia higher (Yahoo Finance)
03:55PM	Analyst Report: Kimberly-Clark Corporation (Morningstar Research)
03:45PM	Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal. (Barrons.com)
03:00PM	Is the End of the Line Near for Kenvue? (The Wall Street Journal)
02:23PM	Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger (TheStreet)
02:13PM	Kimberly-Clark bets $40 billion on Kenvue despite Tylenol controversy (Reuters Videos)
02:12PM	Kimberly-Clark risks migraine with Kenvue deal (Financial Times)
02:05PM	Squawk Pod: Big Tech's big challenges & Transportation Sec. Sean Duffy - 11/03/25 Audio Only (CNBC TV)
12:58PM	Stocks to Watch Monday: Kenvue, IREN, Berkshire, Amazon (The Wall Street Journal)
12:40PM	Drug giant hit by Trump autism claims bought for record $49bn (The Telegraph)
12:29PM	Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More (Investopedia)
11:58AM	Kimberly-Clark to Buy Kenvue in $48.7 Billion Deal (GuruFocus.com)
11:33AM	Tylenol trust crisis: Trump, RFK Jr. and Texas lawsuits slam Kenvue (TheStreet)
11:30AM	Halper Sadeh LLC Encourages KVUE, REVG, KMB Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:26AM	Why Kimberly-Clark Stock Just Dropped (Motley Fool)
11:26AM	Stock Market Today: Stocks Rise To Start Week As Tylenol Maker Kenvue Inks $48.7 Billion Megadeal (TheStreet)
11:25AM	S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue soars after buyout (Reuters)
11:17AM	Tylenol Maker Eyes Best Day Ever on Kimberly-Clark Deal (Schaeffer's Research)
11:15AM	Kimberly-Clark Stock Heads for Biggest One-Day Drop Since Black Monday (The Wall Street Journal)
11:01AM	Pre-Markets Mixed to Start November (Zacks)
10:59AM	Kimberly-Clark to buy maker of Tylenol in $48.7 billion cash-and-stock deal (Milwaukee Journal Sentinel)
10:54AM	Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know (Investopedia)
10:43AM	Why Tylenol Maker Kenvue Stock Just Popped (Motley Fool)
10:34AM	Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal (CBS News)
10:33AM	Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day. (The Wall Street Journal)
10:23AM	Pre-markets Mixed on Big Staples Acquisition (Zacks)
10:18AM	Tylenol maker Kenvue leads S&P 500, boosted by $48.7 billion Kimberly-Clark deal (MarketWatch)
10:05AM	Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant (CNBC TV)
09:55AM	These Stocks Are Moving the Most Today: Kenvue, Kimberly-Clark, Amazon, Berkshire Hathaway, Palantir, IREN, Cipher Mining, and More (Barrons.com)
09:37AM	Stock market today: S&P 500, Nasdaq jump to kick off November as Amazon, Nvidia lead way (Yahoo Finance)
09:37AM	Stock market today: Dow slips, Nasdaq pops as Amazon's OpenAI deal boosts AI bets (Yahoo Finance)
09:35AM	Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking. (Barrons.com)
09:34AM	Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal (Yahoo Finance Video)
09:33AM	Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal (Bloomberg)
09:16AM	Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger (The Guardian)
09:15AM	Berkshire earnings, Kimberly-Clark's deal to buy Tylonel maker (Yahoo Finance Video)
09:05AM	Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal (CNBC TV)
08:47AM	Kimberly-Clark to Buy Tylenol Maker Kenvue in $48.7B Deal. Kimberly-Clark Stock Tanks. (Barrons.com)
08:43AM	Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal (USA TODAY)
08:41AM	Tylenol Maker Scooped Up In $49 Billion Deal (Investor's Business Daily)
08:27AM	Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion (MarketWatch)
08:21AM	Kimberly-Clark is buying Tylenol maker Kenvue for more than $48 billion (Quartz)
08:19AM	Kimberly-Clark buys Tylenol maker Kenvue for more than $48 billion (Quartz)
07:42AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:38AM	It's been a disappointing ride for many Kenvue shareholders (MarketWatch)
07:22AM	Kenvue jumps 22% on $48.7 billion Kimberly-Clark merger deal (Investing.com)
07:22AM	Kimberly-Clark to Buy Tylenol Maker Kenvue for More Than $40 Billion (The Wall Street Journal)
07:18AM	Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal, creating a massive consumer health goods company (Associated Press Finance)
06:50AM	Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion (Barrons.com)
06:47AM	Kimberly-Clark to Acquire Kenvue (WWD)
06:44AM	Kimberly-Clark to Buy Tylenol Maker Kenvue (The Wall Street Journal)
06:37AM	Kenvue: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader (PR Newswire)
06:30AM	Kenvue Reports Third Quarter 2025 Results (Business Wire)
06:15AM	Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks? (Motley Fool)
04:31AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to rise as Buffett's Berkshire Hathaway builds cash, more earnings await (MarketWatch)
Nov-02-25 07:06PM	Stock market today: Dow, S&P 500, Nasdaq futures climb as November kicks off with earnings, AI, Fed in focus (Yahoo Finance)
Nov-01-25 07:05AM	These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming? (Motley Fool)
Oct-31-25 04:27AM	Do Wall Street Analysts Like Kenvue Stock? (Barchart)
Oct-30-25 09:38PM	Jefferies and Deutsche Bank Lower Price Targets on Kenvue (KVUE) (Insider Monkey)
04:27PM	Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations (MarketBeat)
10:00AM	Earnings Preview: Kenvue (KVUE) Q3 Earnings Expected to Decline (Zacks)
09:57AM	Jefferies Lowers Kenvue (KVUE) PT to $23, Cites Macroeconomic Headwinds for Consumer Health (Insider Monkey)
Oct-29-25 11:57AM	Deutsche Bank Lowers Kenvue (KVUE) PT to $18, Keeps a Hold Rating (Insider Monkey)
09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Howlett Heather	VP & Chief Accounting Officer	Oct 03 '25	Option Exercise	0.00	27,181	0	30,901	Oct 07 04:32 PM
Dyer Russell	Chief Corp. Affairs Officer	Jun 03 '25	Option Exercise	0.00	2,669	0	2,669	Jun 05 04:27 PM
Ruh Paul	Former Officer	May 16 '25	Proposed Sale	24.03	100,531	2,415,700		May 16 02:23 PM
Ruh Paul	Former Officer	May 12 '25	Proposed Sale	24.26	50,000	1,213,000		May 12 10:42 AM
Lawson Carlton	Group President EMEA & LA	Mar 13 '25	Sale	23.03	17,100	393,813	56,316	Mar 14 04:23 PM
Lawson Carlton	Officer	Mar 13 '25	Proposed Sale	23.03	17,100	393,871		Mar 13 02:12 PM
Lawson Carlton	Group President EMEA & LA	Mar 05 '25	Option Exercise	0.00	7,422	0	73,416	Mar 07 05:03 PM
Meurer Jan	Group President, North America	Mar 05 '25	Option Exercise	0.00	6,913	0	35,677	Mar 07 05:03 PM
Tillett Caroline	Chief Scientific Officer	Mar 05 '25	Option Exercise	0.00	4,268	0	45,658	Mar 07 05:03 PM
Howlett Heather	VP & Chief Accounting Officer	Mar 05 '25	Option Exercise	0.00	2,613	0	4,582	Mar 07 05:03 PM
Ruh Paul	Chief Financial Officer	Mar 05 '25	Option Exercise	0.00	7,422	0	59,996	Mar 07 05:02 PM
Tavares Bernardo	Chief Tech & Data Officer	Mar 05 '25	Option Exercise	0.00	1,503	0	14,582	Mar 07 05:02 PM
Alvarado Luani	Chief People Officer	Mar 05 '25	Option Exercise	0.00	4,107	0	32,688	Mar 07 05:02 PM
Xie Bing	Group President APAC	Mar 05 '25	Option Exercise	0.00	6,169	0	50,688	Mar 07 05:02 PM
England Charmaine	Chief Growth Officer	Mar 05 '25	Option Exercise	0.00	2,911	0	30,407	Mar 07 05:02 PM
Orlando Matthew	General Counsel	Mar 05 '25	Option Exercise	0.00	6,169	0	28,439	Mar 07 05:01 PM
Stevens Meredith	Chief Operations Officer	Mar 05 '25	Option Exercise	0.00	5,971	0	66,865	Mar 07 05:01 PM
Mongon Thibaut	Chief Executive Officer	Mar 05 '25	Option Exercise	0.00	32,969	0	233,333	Mar 07 05:01 PM
Ruh Paul	Chief Financial Officer	Feb 14 '25	Option Exercise	0.00	31,863	0	59,790	Feb 18 06:30 PM
Ruh Paul	Chief Financial Officer	Feb 13 '25	Option Exercise	0.00	2,600	0	31,596	Feb 18 06:30 PM
Howlett Heather	VP & Chief Accounting Officer	Feb 13 '25	Option Exercise	0.00	1,556	0	2,544	Feb 18 06:30 PM
Stevens Meredith	Chief Operations Officer	Feb 14 '25	Option Exercise	0.00	34,278	0	67,771	Feb 18 06:30 PM
Stevens Meredith	Chief Operations Officer	Feb 13 '25	Option Exercise	0.00	3,215	0	37,070	Feb 18 06:30 PM
Lawson Carlton	Group President EMEA & LA	Feb 14 '25	Option Exercise	0.00	41,464	0	65,994	Feb 18 06:30 PM
Lawson Carlton	Group President EMEA & LA	Feb 13 '25	Option Exercise	0.00	4,519	0	24,530	Feb 18 06:30 PM
Xie Bing	Group President APAC	Feb 14 '25	Option Exercise	0.00	40,323	0	58,737	Feb 18 06:29 PM
Xie Bing	Group President APAC	Feb 13 '25	Option Exercise	0.00	4,126	0	26,351	Feb 18 06:29 PM
Mongon Thibaut	Chief Executive Officer	Feb 14 '25	Option Exercise	0.00	162,365	0	270,403	Feb 18 06:29 PM
Mongon Thibaut	Chief Executive Officer	Feb 13 '25	Option Exercise	0.00	8,438	0	124,220	Feb 18 06:29 PM
Orlando Matthew	General Counsel	Feb 14 '25	Option Exercise	0.00	11,490	0	25,763	Feb 18 06:29 PM
Orlando Matthew	General Counsel	Feb 13 '25	Option Exercise	0.00	1,371	0	16,209	Feb 18 06:29 PM
Tavares Bernardo	Chief Tech & Data Officer	Feb 14 '25	Option Exercise	0.00	9,416	0	15,980	Feb 18 06:29 PM
Tavares Bernardo	Chief Tech & Data Officer	Feb 13 '25	Option Exercise	0.00	1,333	0	8,261	Feb 18 06:29 PM
Tillett Caroline	Chief Scientific Officer	Feb 14 '25	Option Exercise	0.00	26,766	0	47,625	Feb 18 06:29 PM
Tillett Caroline	Chief Scientific Officer	Feb 13 '25	Option Exercise	0.00	3,000	0	24,490	Feb 18 06:29 PM
Meurer Jan	Group President, North America	Feb 14 '25	Option Exercise	0.00	16,202	0	32,933	Feb 18 06:29 PM
Meurer Jan	Group President, North America	Feb 13 '25	Option Exercise	0.00	2,119	0	19,271	Feb 18 06:29 PM
England Charmaine	Chief Growth Officer	Feb 14 '25	Option Exercise	0.00	13,038	0	31,796	Feb 18 06:29 PM
England Charmaine	Chief Growth Officer	Feb 13 '25	Option Exercise	0.00	1,289	0	21,075	Feb 18 06:29 PM
Alvarado Luani	Chief People Officer	Feb 14 '25	Option Exercise	0.00	17,009	0	32,586	Feb 18 06:28 PM
Alvarado Luani	Chief People Officer	Feb 13 '25	Option Exercise	0.00	1,830	0	17,675	Feb 18 06:28 PM
Meurer Jan	Group President, North America	Dec 01 '24	Option Exercise	0.00	2,330	0	18,345	Dec 03 06:38 PM
Tillett Caroline	Chief Scientific Officer	Dec 01 '24	Option Exercise	0.00	1,498	0	22,257	Dec 03 06:38 PM
Stevens Meredith	Chief Operations Officer	Dec 01 '24	Option Exercise	0.00	2,930	0	35,008	Dec 03 06:38 PM
Ruh Paul	Chief Financial Officer	Dec 01 '24	Option Exercise	0.00	4,095	0	30,894	Dec 03 06:38 PM
Xie Bing	Group President APAC	Dec 01 '24	Option Exercise	0.00	1,531	0	22,811	Dec 03 06:38 PM
Mongon Thibaut	Chief Executive Officer	Dec 01 '24	Option Exercise	0.00	7,323	0	119,528	Dec 03 06:37 PM
Alvarado Luani	Chief People Officer	Dec 01 '24	Option Exercise	0.00	2,164	0	16,948	Dec 03 06:37 PM
Orlando Matthew	General Counsel	Dec 01 '24	Option Exercise	0.00	4,261	0	15,778	Dec 03 06:37 PM
Lawson Carlton	Group President EMEA & LA	Dec 01 '24	Option Exercise	0.00	1,731	0	20,011	Dec 03 06:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KVUE

Kenvue Inc

Upgrade your FINVIZ experience